Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational
 BSE Code
 500660
ISIN Demat
INE159A01016
Book Value
100.5174369
Mar.Cap(Rs.Cr)
40,225.46
P/E
42.50
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Profit And Loss
ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
INCOME :      
Sales Turnover 3723.493407.253216.343217.512920.483224.68
Excise Duty0.000.000.000.000.000.00
Net Sales3723.493407.253216.343217.512920.483224.68
Other Income 147.26143.17114.961423.27217.71624.37
Stock Adjustments -51.2369.64-67.25-13.8326.1235.43
Total Income3819.523620.063264.054626.953164.313884.48
EXPENDITURE :      
Raw Materials 1315.971358.071182.781281.911275.491343.30
Power & Fuel Cost30.1829.6429.6027.8326.0833.36
Employee Cost 579.70624.39594.99610.23616.16628.55
Other Manufacturing Expenses 114.26113.6199.05120.14110.59107.88
Selling & Administrative Expenses 383.95374.71370.30343.57242.00376.68
Miscellaneous Expenses 78.91239.1284.3285.69287.75983.19
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure2502.982739.542361.042469.382558.073472.96
Operating Profit1316.54880.52903.012157.57606.24411.52
Interest 1.311.801.811.993.536.34
Gross Profit1315.23878.72901.202155.58602.71405.18
Depreciation66.7969.6865.7768.1978.6082.68
Profit Before Tax1248.44809.04835.432087.39524.11322.50
Tax323.18235.71246.05407.36158.67260.17
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax6.20-11.36-18.37-10.497.87-47.72
Reported Net Profit919.05584.69607.751690.53357.57110.05
Extraordinary Items 53.61-66.5821.0511.18-117.79-87.09
Adjusted Net Profit865.44651.27586.701679.35475.36197.14
Adjustment below Net Profit 0.000.00-17.08-11.050.00-76.80
P & L Balance brought forward870.71828.121745.02562.71882.771181.17
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 745.39542.101524.66508.22677.62338.81
P & L Balance carried down1044.37870.71811.031733.98562.71875.62
Dividend203.290.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %540.00320.00320.00900.00300.00400.00
Dividend Per Share(Rs)54.0032.0032.0090.0030.0040.00
Earnings Per Share-Unit Curr54.2534.5135.8899.7921.116.50
Earnings Per Share(Adj)-Unit Curr54.2534.5135.8899.7921.116.50
Book Value-Unit Curr115.06105.31103.48158.0688.37108.62
Book Value(Adj)-Unit Curr115.06105.31103.48158.0688.37108.62
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)